Titanocene-Based Method for Indole Synthesis
J. Am. Chem. Soc., Vol. 120, No. 13, 1998 3073
2941, 2865, 1459, 1106, 882 cm-1. Anal. Calcd for C22H37NOSi: C,
73.48; H, 10.37. Found: C, 73.74; H, 10.59.
IR (KBr) 3406, 2880, 2838, 2536, 1492, 1458, 1436, 1064 cm-1. Anal.
Calcd for C20H20N2: C, 83.30; H, 6.99. Found: C, 83.55; H, 7.28.
Table 1, Entry 2: 7-Methyl-3-[2-phenyl-2-[(triisopropylsilyl)oxy]-
ethyl]indole. The title compound (0.10 g, 40% from Cp2TiCl2) was
prepared as a colorless oil using general procedure A and was purified
2-Methyl-6-vinyl-N-benzylaniline (7). A mixture of Pd2(dba)3 (41
mg, 2 mol %), P(o-tolyl)3 (84 mg, 6 mol %), and NaO-t-Bu (0.30 g,
3.16 mmol) was added to a solution of the dibromide 4 (0.63 g, 2.26
mmol) in toluene, and the flask was heated to 80 °C for 16 h. Upon
cooling to RT, the solution was poured into a separatory funnel
containing H2O and Et2O. The organic layer was washed with brine,
dried over MgSO4, and filtered, and the solvents were removed in vacuo.
The product was purified by flash chromatography (20:1 hexane/ethyl
acetate) to give 0.19 g (38%) of a yellow oil: 1H NMR (250 MHz,
CDCl3) δ 7.62-7.56 (m, 6 H), 7.36-7.30 (m, 2 H), 7.19 (t, J ) 7.5
Hz, 1 H), 5.93 (dd, J ) 1.6, 19.2 Hz, 1 H), 5.54 (dd, J ) 1.6, 10.8 Hz,
1 H), 4.43 (s, 2 H), 3.63 (br s, 1 H), 2.45 (s, 3 H); 13C NMR (75 MHz,
CDCl3) δ 145.0, 140.4, 134.6, 130.8, 130.1, 129.4, 128.5, 127.8, 127.3,
125.2, 122.2, 114.4, 54.0, 18.0; IR (neat) 3367, 3028, 2928, 1591, 1464,
by flash chromatography (2:1 hexane/Et2O):[R]25 ) +23.9 (c 1.09,
D
CHCl3); HPLC Chiralcel OD 25 cm × 0.46 cm column (Daicel
Chemical Ind., Ltd.), eluent 99:1 hexane/isopropyl alcohol, flow rate
0.5 mL/min, detection UV 254 nm, retention time for (S)-enantiomer
23.6 min, retention time for (R)-enantiomer 25.5 min, optical purity
67% ee; 1H NMR (300 MHz, CDCl3) δ 7.7 (br s, 1H), 7.35-6.90 (m,
8H), 6.56 (m, 1H), 5.01 (dd, J ) 5.4, 8.0 Hz, 1 H), 3.31 (dd, J ) 5.4,
14.0 Hz, 1 H), 3.05 (dd, J ) 8.0, 14.0 Hz, 1 H), 2.43 (s, 3 H), 1.10-
0.85 (m, 21 H); 13C NMR (75 MHz, CDCl3) δ 145.5, 135.6, 127.6,
126.8, 126.5, 122.8, 122.2, 119.9, 119.3, 116.6, 112.8, 75.7, 37.5, 18.0,
17.9, 16.5, 12.4; IR (neat) 3425, 2942, 2865, 1460, 1090, 1065, 882
cm-1. Anal. Calcd for C26H37NOSi: C, 76.60; H, 9.15. Found: C,
76.79; H, 8.96.
700 cm-1
.
Table 2, Entry 1: 7-Methylindole.16 Cp2TiCl2 (2.61 g, 10.48 mmol)
in toluene (70 mL) was employed according to general procedure B.
The indole product was purified by flash chromatography (10:1 hexane/
ethyl acetate) to yield 0.56 g of a white solid (40% from Cp2TiCl2):
mp 80-82 °C; H NMR (300 MHz, CDCl3) δ 8.02 (br s, 1 H), 7.56
(d, J ) 7.5 Hz, 1 H), 7.20 (m, 1 H), 7.10 (t, J ) 7.3 Hz, 1 H), 7.04 (d,
J ) 7.3 Hz, 1 H), 6.60 (s, 1 H), 2.52 (s, 3 H).
Table 2, Entry 2: 4-Methoxy-7-methylindole. Cp2TiCl2 (0.93 g,
3.75 mmol) in toluene (25 mL) was employed according to general
procedure B. The indole product was purified by flash chromatography
(10:1 hexane/ethyl acetate) to yield 0.21 g of a colorless oil (34% from
Cp2TiCl2): 1H NMR (300 MHz, CDCl3) δ 8.06 (br s, 1 H), 7.11 (s, 1
H), 6.94 (d, J ) 7.7 Hz, 1 H), 6.72 (s, 1 H), 6.50 (d, J ) 7.7 Hz, 1 H),
3.98 (s, 3 H), 2.45 (s, 3 H); 13C NMR (75 MHz, CDCl3) δ 151.8, 136.6,
122.6, 122.5, 118.0, 113.3, 100.3, 99.6, 55.4, 16.0; IR (KBr) 3394,
3105, 2962, 1524, 1500, 1262 cm-1. Anal. Calcd for C10H11NO: C,
74.51; H, 6.88. Found: C, 74.59; H, 7.22.
Table 1, Entry 3: 3-Butyl-7-methylindole. The title compound
(47 mg, 54% from Cp2TiCl2) was prepared as colorless needles using
general procedure A and was purified by flash chromatography (3:1
1
hexane/CH2Cl2): mp 39.5-40.0 °C; H NMR (300 MHz, CDCl3) δ
1
7.80 (br s, 1 H), 7.47 (d, J ) 7.5 Hz, 1 H), 7.10-6.95 (m, 3 H), 2.75
(t, J ) 7.0 Hz, 2 H), 2.48 (s, 3 H), 1.75-1.60 (m, 2 H), 1.42 (sextet,
J ) 7.0 Hz, 2 H), 0.95 (t, J ) 7.0 Hz, 3 H); 13C NMR (75 MHz,
CDCl3) δ 135.9, 127.2, 122.3, 120.7, 120.1, 119.3, 117.7, 116.8, 32.4,
25.0, 22.7, 16.6, 14.0; IR (KBr) 3433, 2960, 2920, 2855, 1464, 1430,
1100, 1066, 788, 745 cm-1. Anal. Calcd for C13H17N: C, 83.37; H,
9.15. Found: C, 83.40; H, 9.33.
Table 1, Entry 4: 3-Butyl-4,7-dimethylindole. The title compound
(88 mg, 37% from Cp2TiCl2) was prepared as colorless needles using
general procedure A and was purified by flash chromatography (3:1
hexane/CH2Cl2): mp 73.5-74 °C; 1H NMR (300 MHz, CDCl3) δ 7.77
(br s, 1 H), 6.94 (s, 1 H), 6.85 (d, J ) 7.1 Hz, 1 H), 6.75 (d, J ) 7.1
Hz, 1 H), 2.90 (t, J ) 7.4 Hz, 2 H), 2.68 (s, 3 H), 2.42 (s, 3 H), 1.67
(m, 2 H), 1.47 (sextet, J ) 7.3 Hz, 2 H), 0.97 (t, J ) 7.3 Hz, 3 H); 13
C
NMR (75 MHz, CDCl3) δ 136.3, 128.6, 125.5, 122.2, 120.9, 118.8,
Table 2, Entry 3: 3-Butyl-7-methoxyindole. The title compound
(65 mg, 43% from Cp2TiCl2) was prepared as a colorless oil using
general procedure C and was purified by flash chromatography (4:1
hexane/CH2Cl2): 1H NMR (250 MHz, CDCl3) δ 8.10 (br s, 1H), 7.22
(d, J ) 7.8 Hz, 1 H), 7.02 (t, J ) 7.8 Hz, 1 H), 6.9 (m, 1 H), 6.62 (d,
J ) 7.8 Hz, 1 H), 3.93 (s, 3 H), 2.73 (t, J ) 7.3 Hz, 2 H), 1.75-1.55
117.7, 33.7, 26.9, 22.6, 20.0, 16.2, 14.0; IR (KBr) 3425, 2953, 2856,
1511, 803 cm-1
. Anal. Calcd for C14H19N: C, 83.53; H, 9.51.
Found: C, 83.76; H, 9.79.
Table 1, Entry 5: 3-Butylnaphthoindole. The title compound (43
mg, 35% from Cp2TiCl2) was prepared as colorless needles using
general procedure A and was purified by flash chromatography (4:1
hexane/CH2Cl2): mp 132-133 °C; 1H NMR (300 MHz, CDCl3) δ 8.6
(br s, 1H), 7.98 (d, J ) 8.4 Hz, 1 H), 7.92 (d, J ) 8.4 Hz, 1 H), 7.71
(d, J ) 9.3 Hz, 1 H), 7.55-7.38 (m, 3 H), 7.06 (m, 1H), 2.83 (t, J )
7 Hz, 2 H), 1.80-1.64 (m, 2 H), 1.45 (sextet, J ) 7.2 Hz, 2 H), 0.97
(t, J ) 7.2 Hz, 3 H); 13C NMR (62.5 MHz, CDCl3) δ 130.8, 130.4,
128.8, 125.3, 123.7, 123.4, 121.8, 119.9, 119.3, 119.2, 119.0, 32.7,
24.9, 22.6, 14.0; IR (KBr) 3411, 2957, 2915, 2855, 1524, 1452, 1392,
811 cm-1. Anal. Calcd for C16H17N: C, 86.05; H, 7.67. Found: C,
86.34; H, 7.83.
(m, 2 H), 1.40 (sextet, J ) 7.2 Hz, 2 H), 0.94 (t, J ) 7.2 Hz, 3 H); 13
C
NMR (75 MHz, CDCl3) δ 146.1, 129.0, 126.8, 120.6, 119.4, 117.5,
111.8, 101.7, 55.3, 32.4, 25.0, 22.6, 14.0; IR (neat) 3416, 2952, 2927,
2854, 1577, 1498, 1446, 1373, 1258, 1077, 1040 cm-1. Anal. Calcd
for C13H17NO: C, 76.81; H, 8.43. Found: C, 77.08; H, 8.56.
Table 2, Entry 4: 3-[8-(tert-Butoxycarbonyl)octyl]-7-methylindole.
The title compound (86 mg, 33% from Cp2TiCl2) was prepared as
colorless needles using general procedure C and was purified by flash
chromatography (3:1 hexane/Et2O): mp 57-58 °C; 1H NMR (300
MHz, CDCl3) δ 7.8 (br s, 1H), 7.46 (d, J ) 7.8 Hz, 1 H), 7.08-6.95
(m, 3 H), 2.73 (t, J ) 7.2 Hz, 2 H), 2.48 (s, 3 H), 2.19 (t, J ) 6.9 Hz,
2 H), 1.76-1.50 (m, 4 H), 1.44 (s, 9 H), 1.42-1.20 (m, 8 H); 13C
NMR (75 MHz, CDCl3) δ 173.4, 135.9, 127.1 122.3, 120.7, 120.1,
119.2, 117.6, 116.7, 79.9, 35.6, 30.2, 29.5, 29.3, 29.1, 28.1, 25.3, 25.1,
16.6; IR (KBr) 3356, 2917, 2849, 1718, 1466, 1160 cm-1. Anal. Calcd
for C22H33NO2: C, 76.92; H, 9.68. Found: C, 77.15; H, 9.95.
Table 1, Entry 6: 3-Butyl-4-methoxy-7-methylindole. The title
compound (0.12 g, 18% from Cp2TiCl2) was prepared as a colorless
oil using general procedure A and was purified by flash chromatography
(10:1 hexane/ethyl acetate): 1H NMR (300 MHz, CDCl3) δ 7.76 (br s,
1 H), 6.86 (m, 2 H), 6.40 (d, J ) 7.9 Hz, 1 H), 3.89 (s, 3 H), 2.87 (t,
J ) 7.4 Hz, 2 H), 2.39 (s, 3 H), 1.66 (m, 2 H), 1.42 (sextet, J ) 7.3
Hz, 2 H), 0.95 (t, J ) 7.3 Hz, 3 H); 13C NMR (75 MHz, CDCl3) δ
146.8, 137.4, 122.4, 119.5, 118.5, 113.0, 99.3, 97.3, 55.2, 42.0, 33.4,
26.5, 22.6, 14.1; IR (neat) 3470, 2958, 2861, 1604, 1515, 1264 cm-1
.
Acknowledgment. We thank the National Institutes of
Health for support of this work. We thank Boulder Scientific
for a generous gift of titanocene dichloride. We thank Prof.
Richard R. Schrock and Prof. Christopher C. Cummins for the
donation of high-purity ethylene. Dr. Kazumasa Aoki gratefully
acknowledges support from the Uehara Memorial Foundation.
We also thank Dr. Bryant Yang for considerable help in the
preparation of the manuscript.
Anal. Calcd for C14H19NO: C, 77.38; H, 8.81. Found: C, 77.44; H,
9.04.
7-Methyl-3-[2-(7-methyl-3-indolyl)ethyl]indole (3). The title com-
pound (26 mg, 16% from 1,5-hexadiene) was prepared as colorless
needles from Cp2TiCl2 (2 mol equiv) and 1,5-hexadiene (1 mol equiv)
using general procedure A and was purified by flash chromatography
(2:1 hexane/acetone): mp 225-226 °C; 1H NMR (250 MHz, acetone-
d6) δ 9.90 (br s, 2 H), 7.49 (d, J ) 7.1 Hz, 2 H), 7.15 (m, 2 H), 7.05-
6.85 (m, 4 H), 3.15 (s, 4 H), 2.49 (s, 6 H); 13C NMR (75 MHz, acetone-
d6) δ 137.2, 128.5, 122.7, 122.6, 122.4, 121.3, 119.7, 117.3, 27.4, 17.0;
JA972281P